These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9093811)

  • 41. Advances in understanding and treatment of Tourette syndrome.
    McNaught KS; Mink JW
    Nat Rev Neurol; 2011 Nov; 7(12):667-76. PubMed ID: 22064610
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gilles de la Tourette syndrome and deep brain stimulation.
    Hariz MI; Robertson MM
    Eur J Neurosci; 2010 Oct; 32(7):1128-34. PubMed ID: 21039952
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tourette syndrome, co-morbidities and quality of life.
    Eapen V; Snedden C; Črnčec R; Pick A; Sachdev P
    Aust N Z J Psychiatry; 2016 Jan; 50(1):82-93. PubMed ID: 26169656
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deep Brain Stimulation in Gilles de la Tourette Syndrome: What Does the Future Hold? A Cohort of 48 Patients.
    Servello D; Zekaj E; Saleh C; Lange N; Porta M
    Neurosurgery; 2016 Jan; 78(1):91-100. PubMed ID: 26348012
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gilles de la Tourette syndrome - A treatable condition?
    Hartmann A; Martino D; Murphy T
    Rev Neurol (Paris); 2016; 172(8-9):446-454. PubMed ID: 27476415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tourette syndrome: evolving concepts.
    Jankovic J; Kurlan R
    Mov Disord; 2011 May; 26(6):1149-56. PubMed ID: 21484868
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 2: tentative explanations for differing prevalence figures in GTS, including the possible effects of psychopathology, aetiology, cultural differences, and differing phenotypes.
    Robertson MM
    J Psychosom Res; 2008 Nov; 65(5):473-86. PubMed ID: 18940378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The colorful spectrum of Tourette syndrome and its medical, surgical and behavioral therapies.
    Roth J
    Parkinsonism Relat Disord; 2018 Jan; 46 Suppl 1():S75-S79. PubMed ID: 28807495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The psychopathological spectrum of Gilles de la Tourette syndrome.
    Cavanna AE; Rickards H
    Neurosci Biobehav Rev; 2013 Jul; 37(6):1008-15. PubMed ID: 23131314
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gilles de la Tourette syndrome is not linked to D2-dopamine receptor.
    Gelernter J; Pakstis AJ; Pauls DL; Kurlan R; Gancher ST; Civelli O; Grandy D; Kidd KK
    Arch Gen Psychiatry; 1990 Nov; 47(11):1073-7. PubMed ID: 1978653
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gilles de la Tourette's syndrome with and without obsessive-compulsive disorder compared with obsessive-compulsive disorder without tics: which symptoms discriminate?
    Cath DC; Spinhoven P; van Woerkom TC; van de Wetering BJ; Hoogduin CA; Landman AD; Roos RA; Rooijmans HG
    J Nerv Ment Dis; 2001 Apr; 189(4):219-28. PubMed ID: 11339317
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reinforcement learning and Gilles de la Tourette syndrome: dissociation of clinical phenotypes and pharmacological treatments.
    Worbe Y; Palminteri S; Hartmann A; Vidailhet M; Lehéricy S; Pessiglione M
    Arch Gen Psychiatry; 2011 Dec; 68(12):1257-66. PubMed ID: 22147843
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tourette syndrome: recent advances.
    Golden GS
    Neurol Clin; 1990 Aug; 8(3):705-14. PubMed ID: 2215464
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recent advances in Gilles de la Tourette syndrome: implications for clinical practice and future research.
    Leckman JF; Cohen DJ
    Psychiatr Dev; 1983; 1(3):301-16. PubMed ID: 6324164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The treatment of children with Gilles de la Tourette's syndrome].
    Minderaa RB
    Tijdschr Kindergeneeskd; 1987 Feb; 55(1):10-5. PubMed ID: 2882617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome. The Tourette Syndrome Association International Consortium for Genetics.
    Am J Hum Genet; 1999 Nov; 65(5):1428-36. PubMed ID: 10521310
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical analysis of Gilles de la Tourette syndrome based on 126 cases.
    Janik P; Kalbarczyk A; Sitek M
    Neurol Neurochir Pol; 2007; 41(5):381-7. PubMed ID: 18033637
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Control of inner speech and Gilles de la Tourette's syndrome].
    Vercueil L
    Encephale; 2003; 29(5):460-2. PubMed ID: 14615696
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tics.
    Pringsheim T; Davenport WJ; Lang A
    Curr Opin Neurol; 2003 Aug; 16(4):523-7. PubMed ID: 12869813
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Gilles de la Tourette: The history of the man and his illness; a medical historical study].
    Gilson F
    Tijdschr Psychiatr; 2012; 54(7):427-36. PubMed ID: 22811054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.